{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:41:55Z","timestamp":1781574115929,"version":"3.54.5"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clinicians caring for patients infected with Ebola virus must be familiar not only with screening and infection control measures but also with management of severe disease. By integrating experience from several Ebola epidemics with best practices for managing critical illness, this report focuses on the clinical presentation and management of severely ill infants, children, and adults with Ebola virus disease. Fever, fatigue, vomiting, diarrhea, and anorexia are the most common symptoms of the 2014 West African outbreak. Profound fluid losses from the gastrointestinal tract result in volume depletion, metabolic abnormalities (including hyponatremia, hypokalemia, and hypocalcemia), shock, and organ failure. Overt hemorrhage occurs infrequently. The case fatality rate in West Africa is at least 70%, and individuals with respiratory, neurological, or hemorrhagic symptoms have a higher risk of death. There is no proven antiviral agent to treat Ebola virus disease, although several experimental treatments may be considered. Even in the absence of antiviral therapies, intensive supportive care has the potential to markedly blunt the high case fatality rate reported to date. Optimal treatment requires conscientious correction of fluid and electrolyte losses. Additional management considerations include searching for coinfection or superinfection; treatment of shock (with intravenous fluids and vasoactive agents), acute kidney injury (with renal replacement therapy), and respiratory failure (with invasive mechanical ventilation); provision of nutrition support, pain and anxiety control, and psychosocial support; and the use of strategies to reduce complications of critical illness. Cardiopulmonary resuscitation may be appropriate in certain circumstances, but extracorporeal life support is not advised. Among other ethical issues, patients\u2019 medical needs must be carefully weighed against healthcare worker safety and infection control concerns. However, meticulous attention to the use of personal protective equipment and strict adherence to infection control protocols should permit the safe provision of intensive treatment to severely ill patients with Ebola virus disease.<\/jats:p>","DOI":"10.1513\/annalsats.201410-481ps","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T16:44:54Z","timestamp":1415119494000},"page":"1341-1350","source":"Crossref","is-referenced-by-count":79,"title":["Clinical Presentation and Management of Severe Ebola Virus Disease"],"prefix":"10.1093","volume":"11","author":[{"given":"T. Eoin","family":"West","sequence":"first","affiliation":[{"name":"Division of Pulmonary & Critical Care Medicine, Department of Medicine, and"},{"name":"International Respiratory and Severe Illness Center, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"von Saint Andr\u00e9-von Arnim","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington; and"},{"name":"International Respiratory and Severe Illness Center, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"2026012303502006600_bib1","article-title":"W.H.O. Chief calls Ebola outbreak a \u2018crisis for international peace\u2019","author":"N. Cumming-Bruce","year":"2014"},{"key":"2026012303502006600_bib2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012303502006600_bib3","article-title":"Ebola outbreak in West Africa: outbreak distribution map","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib4","article-title":"New modeling tool for response to Ebola virus disease","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in West Africa: the first 9 months of the epidemic and forward projections","volume":"371","author":"WHO Ebola Response Team","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012303502006600_bib6","article-title":"Ebola virus disease","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib7","article-title":"A case of severe Ebola virus infection complicated by gram-negative septicemia","author":"Kreuels","journal-title":"N Engl J Med"},{"key":"2026012303502006600_bib8","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1086\/520548","article-title":"The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005: I. Lessons learned in the hospital","volume":"196","author":"Jeffs","year":"2007","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"2026012303502006600_bib10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMp1405314","article-title":"Ebola: a growing threat?","volume":"371","author":"Feldmann","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012303502006600_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"key":"2026012303502006600_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1009657006550","article-title":"Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?","volume":"5","author":"Baize","year":"2000","journal-title":"Apoptosis"},{"key":"2026012303502006600_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab Invest"},{"key":"2026012303502006600_bib14","article-title":"Clinical features and pathobiology of Ebolavirus infection","author":"Ansari","journal-title":"J Autoimmun"},{"key":"2026012303502006600_bib15","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J Virol"},{"key":"2026012303502006600_bib16","article-title":"Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg Viruses","author":"Martines","journal-title":"J Pathol"},{"key":"2026012303502006600_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.01.152","article-title":"Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions","volume":"78","author":"Bausch","year":"2008","journal-title":"Antiviral Res"},{"key":"2026012303502006600_bib18","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic clinical and laboratory features of filoviral hemorrhagic fever","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib19","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone","author":"Schieffelin","journal-title":"N Engl J Med"},{"key":"2026012303502006600_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201408-1514CP","article-title":"Caring for critically ill patients with Ebola virus disease. Perspectives from west Africa","volume":"190","author":"Fowler","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303502006600_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2012.03.019","article-title":"Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets","volume":"65","author":"Denizot","year":"2012","journal-title":"J Infect"},{"key":"2026012303502006600_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2110-5820-3-15","article-title":"Understanding brain dysfunction in sepsis","volume":"3","author":"Sonneville","year":"2013","journal-title":"Ann Intensive Care"},{"key":"2026012303502006600_bib23","first-page":"60","article-title":"Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations","volume":"1","author":"Mupere","year":"2001","journal-title":"Afr Health Sci"},{"key":"2026012303502006600_bib24","article-title":"Ebola: lessons learned","author":"IDWeek","year":"2014"},{"key":"2026012303502006600_bib25","article-title":"Presby doc on Ebola response: \u2018Epitome of health care'","author":"WFAA","year":"2014"},{"key":"2026012303502006600_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00003246-200001000-00041","article-title":"Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects","volume":"28","author":"Richards","year":"2000","journal-title":"Crit Care Med"},{"key":"2026012303502006600_bib27","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/514289","article-title":"Ebola hemorrhagic fever and pregnancy","volume":"179","author":"Mupapa","year":"1999","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib28","article-title":"What obstetrician-gynecologists should know about Ebola: A perspective from the centers for disease control and prevention","author":"Jamieson","journal-title":"Obstet Gynecol"},{"key":"2026012303502006600_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/bsp.2011.0051","article-title":"Evaluation of perceived threat differences posed by filovirus variants","volume":"9","author":"Kuhn","year":"2011","journal-title":"Biosecur Bioterror"},{"key":"2026012303502006600_bib30","article-title":"Ebola facts: What is being done to improve medical treatment in Africa?","author":"New York Times","year":"2014"},{"key":"2026012303502006600_bib31","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1086\/520613","article-title":"Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus","volume":"196","author":"Rollin","year":"2007","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib32","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels","volume":"78","author":"Sanchez","year":"2004","journal-title":"J Virol"},{"key":"2026012303502006600_bib33","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection","volume":"179","author":"Villinger","year":"1999","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00006454-199603000-00002","article-title":"Ebola hemorrhagic fever: why were children spared?","volume":"15","author":"Dowell","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"2026012303502006600_bib35","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3201\/eid2010.140430","article-title":"Biomarker correlates of survival in pediatric patients with Ebola virus disease","volume":"20","author":"McElroy","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2026012303502006600_bib36","article-title":"Case definition for Ebola virus disease (EVD)","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib37","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s00134-014-3473-7","article-title":"Does this patient have Ebola virus disease?","volume":"40","author":"Tattevin","year":"2014","journal-title":"Intensive Care Med"},{"key":"2026012303502006600_bib38","article-title":"Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib39","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.40.7.2323-2330.2002","article-title":"Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR","volume":"40","author":"Drosten","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2026012303502006600_bib40","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1086\/514313","article-title":"ELISA for the detection of antibodies to Ebola viruses","volume":"179","author":"Ksiazek","year":"1999","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib41","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1086\/520601","article-title":"High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings","volume":"196","author":"Towner","year":"2007","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib42","article-title":"Interim guidance for specimen collection, transport, testing, and submission for patients with suspected infection with Ebola virus disease","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib43","doi-asserted-by":"crossref","first-page":"e52986","DOI":"10.1371\/journal.pone.0052986","article-title":"Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008","volume":"7","author":"Roddy","year":"2012","journal-title":"PLoS ONE"},{"key":"2026012303502006600_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-3156.2008.02202.x","article-title":"Critical care in low-income countries","volume":"14","author":"Baker","year":"2009","journal-title":"Trop Med Int Health"},{"key":"2026012303502006600_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/irv.12086","article-title":"Clinical care for severe influenza and other severe illness in resource-limited settings: the need for evidence and guidelines","volume":"7","author":"Ortiz","year":"2013","journal-title":"Influenza Other Respi Viruses"},{"key":"2026012303502006600_bib46","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1371\/journal.pmed.0050175","article-title":"Strategies to reduce mortality from bacterial sepsis in adults in developing countries","volume":"5","author":"Cheng","year":"2008","journal-title":"PLoS Med"},{"key":"2026012303502006600_bib47","article-title":"What we know about transmission of the Ebola virus among humans","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib48","article-title":"Guidance on personal protective equipment to be used by healthcare workers during management of patients with Ebola virus disease in U.S. hospitals, including procedures for putting on (donning) and removing (doffing)","author":"CDC"},{"key":"2026012303502006600_bib49","article-title":"Q&As on transmission","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib50","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1086\/520545","article-title":"Assessment of the risk of Ebola virus transmission from bodily fluids and fomites","volume":"196","author":"Bausch","year":"2007","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib51","article-title":"Information for healthcare workers and settings","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib52","article-title":"Information resources on Ebola virus disease","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib53","article-title":"Ebola: infection prevention and control recommendations for hospitalized patients with known or suspected Ebola virus disease in U.S. Hospitals","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib54","article-title":"Commentary: health workers need optimal respiratory protection for Ebola","author":"Center for Infectious Disease Research and Policy"},{"key":"2026012303502006600_bib55","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(95)92841-3","article-title":"Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory","volume":"346","author":"Jaax","year":"1995","journal-title":"Lancet"},{"key":"2026012303502006600_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/jir077","article-title":"Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs","volume":"204","author":"Kobinger","year":"2011","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib57","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/srep00811","article-title":"Transmission of Ebola virus from pigs to non-human primates","volume":"2","author":"Weingartl","year":"2012","journal-title":"Sci Rep"},{"key":"2026012303502006600_bib58","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/514286","article-title":"Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure","volume":"179","author":"Roels","year":"1999","journal-title":"J Infect Dis"},{"key":"2026012303502006600_bib59","article-title":"Infection prevention and control (IPC) guidance summary: Ebola guidance package","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib60","article-title":"Preparing for critical care services to patients with Ebola","author":"Decker","journal-title":"Ann Intern Med"},{"key":"2026012303502006600_bib61","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMp1411310","article-title":"Doing today\u2019s work superbly well: treating Ebola with current tools","volume":"371","author":"Lamontagne","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012303502006600_bib62","article-title":"Recommendations for cholera clinical management","author":"PAHO","year":"2010"},{"key":"2026012303502006600_bib63","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/v4091668","article-title":"Clinical management of filovirus-infected patients","volume":"4","author":"Clark","year":"2012","journal-title":"Viruses"},{"key":"2026012303502006600_bib64","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"2026012303502006600_bib65","article-title":"AN frequently asked questions (faqs) regarding Ebola virus disease and dialysis","author":"American Society of Nephrology","year":"2014"},{"key":"2026012303502006600_bib66","article-title":"Guidance on air medical transport for patients with Ebola virus disease","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib67","author":"Extracorporeal Life Support Organization","year":"2014"},{"key":"2026012303502006600_bib68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.345.6195.364","article-title":"Infectious diseases: Ebola drugs still stuck in lab","volume":"345","author":"Enserink","year":"2014","journal-title":"Science"},{"key":"2026012303502006600_bib69","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/14787210.4.6.917","article-title":"Filoviruses: recent advances and future challenges","volume":"4","author":"Bray","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026012303502006600_bib70","article-title":"Chimerix announces emergency investigational new drug applications for brincidofovir authorized by FDA for patients with Ebola virus disease","year":"2014"},{"key":"2026012303502006600_bib71","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S0140-6736(14)61411-2","article-title":"WHO meeting chooses untried interventions to defeat Ebola","volume":"384","author":"Maurice","year":"2014","journal-title":"Lancet"},{"key":"2026012303502006600_bib72","article-title":"Statement on the who consultation on potential Ebola therapies and vaccines","author":"WHO"},{"key":"2026012303502006600_bib73","author":"Mapp Biopharmaceutical","year":"2014"},{"key":"2026012303502006600_bib74","article-title":"FDA modifies Tekmira's tkm-ebola clinical hold to partial hold","year":"2014"},{"key":"2026012303502006600_bib75","article-title":"Ebola treatment trials to be fast-tracked in West Africa","author":"Wellcome Trust","year":"2014"},{"key":"2026012303502006600_bib76","article-title":"Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib77","article-title":"Recommendations for safely performing acute hemodialysis in patients with Ebola virus disease in U.S. hospitals","author":"CDC","year":"2014"},{"key":"2026012303502006600_bib78","article-title":"Ebola clinical care guidelines","author":"Canadian Critical Care Society","year":"2014"},{"key":"2026012303502006600_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1747-5341-9-15","article-title":"Ebola, epidemics, and ethics: what we have learned","volume":"9","author":"Donovan","year":"2014","journal-title":"Philos Ethics Humanit Med"},{"key":"2026012303502006600_bib80","doi-asserted-by":"crossref","first-page":"e145S","DOI":"10.1378\/chest.14-0742","article-title":"Ethical considerations: care of the critically ill and injured during pandemics and disasters. Chest consensus statement","volume":"146","author":"Biddison","year":"2014","journal-title":"Chest"},{"key":"2026012303502006600_bib81","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.201407-1317ST","article-title":"An official American Thoracic Society\/American Association Of Critical-Care Nurses\/American College of Chest Physicians\/Society of Critical Care Medicine Policy Statement: the choosing Wisely\u00ae top 5 list in critical care medicine","volume":"190","author":"Halpern","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303502006600_bib82","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.201403-0593CC","article-title":"Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The consensus for worldwide end-of-life practice for patients in intensive care units (WELPICUS) study","volume":"190","author":"Sprung","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303502006600_bib83","article-title":"Laboratory guidance for the diagnosis of Ebola virus disease. Interim recommendations","author":"WHO","year":"2014"},{"key":"2026012303502006600_bib84","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/11\/9\/1341\/66551906\/annalsats_11_9_1341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/11\/9\/1341\/66551906\/annalsats_11_9_1341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:50:34Z","timestamp":1769158234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/11\/9\/1341\/8431869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201410-481ps","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,11,1]]}}}